Intended for UK Healthcare Professionals only

Header

Register to secure your place at Head Start 2025


Thank you for your interest in attending the Head Start Annual Meeting on the 06 & 07 November 2025 | Leeds

By registering you are giving your consent for Teva to contact you regarding this specific event and similar Teva events.

This promotional meeting is open to HCPs from the UK and IE with an interest in headache and migraine management.

This meeting has a limited number of places, your place will not be guaranteed until you receive e-mail confirmation from the meeting Secretariat.


Contact details

Fields marked * are compulsory

How did you hear about this meeting? *
Title
  • DATA PROTECTION INFORMATION

Information marked with an '*' is required for us to fulfill your registration. If you do not provide this information you will not be able to attend the meeting. We will use the information you provide to register you for this event and to communicate with you about this event. If you give permission, we will also use the information to communicate with you on upcoming events. We will also use the information to arrange sponsorship and to comply with our obligations to publish details of payments and benefits provided to healthcare professionals. For more information and for information about your data protection rights, including to object to some processing or to ask to withdraw any permissions you have given, see the full Privacy Policy


Meeting preferences

I will attend the full meeting and will require accommodation to be booked at the meeting venue for the evening of Thursday 06 November 2025 *

Accommodation is available to all delegates should you require it. Single occupancy and breakfast costs will be covered by the meeting sponsors.

I live over 50 miles from the meeting venue and will require travel to be booked for me:*



I live within 50 miles from the meeting venue but will require parking:

The meeting Secretariat will only arrange travel for journeys that meet all necessary requirements.


  • IMPORTANT DISCLOSURE INFORMATION »

Consent to processing of my personal data

Please choose an option: *

This promotional meeting is open to HCPs from the UK and IE with an interest in headache and migraine management. It is organised and funded by Teva UK Limited. Views provided by the speakers are their own and not necessarily shared by Teva UK Limited. Information at the meeting may discuss drug classes where Teva has a product. Prescribing Information and Adverse Event reporting will be available at the meeting.

Teva UK Limited, Ridings Point, Whistler Drive, Castleford, WF10 5HX
+44(0)1977 628500 | www.tevauk.com

2025 Teva UK Limited. All Rights Reserved.
D: MIG-GB-00626 / T: MIG-GB-00627 / M: MIG-GB-00628
Date of Preparation: August 2025